Clinical Decision Support
at Stanford Medicine Children's Health
Welcome to Stanford Medicine Children's Health Clinical Decision Support Hub – offering a variety of tools crafted to provide physicians and other health professionals assistance with clinical decision-making. Our library is designed to be EMR agnostic, allowing for seamless integration into any Electronic Medical Record system.
We are committed to engaging clinicians in the development process to effectively address real-world challenges. By adopting clinician-driven innovations and a rapid, iterative development cycle, we aim to quickly evaluate and refine our tools based on user feedback. This allows for efficient integration with existing EHR systems, real-time data access, and enhanced clinical workflows. By sharing these resources, we aim to foster collaboration in the medical community to build a foundation for digital transformation and improve care delivery at Stanford Medicine Children's Health and institutions everywhere.
By leveraging our core competencies in Clinical Informatics and Software Design, as well as partnering with key stakeholders, we are dedicated to turning innovative ideas into practical, impactful solutions. We invite you to explore our tools and join us in this journey to enhance patient care and drive digital health innovation.
BiliRecs helps clinicians determine treatments for indirect hyperbilirubinemia in newborns 35 weeks or older, following AAP 2022 guidelines. It offers phototherapy or exchange transfusion recommendations to reduce severe hyperbilirubinemia and related neurotoxicity risks.
A platform that integrates with electronic health records to visualize continuous glucose monitor (CGM) data trends, including AGP, GMI, daily, weekly, and more. It aids in diabetes management by detecting glucose abnormalities and generating comprehensive visualizations to guide treatment decisions.
HipTrender is essential for diagnosing and treating developmental dysplasia of the hip (DDH) in children. It uses radiographic parameters, including the acetabular index (AI) and acetabular depth ratio (ADR), to monitor hip development over the years based on standardized reference curves. Applicable for children up to 14 years old.
Created for the assessment and management of childhood hypertension, Hyperisk aids healthcare providers in evaluating risk factors and making informed treatment decisions to prevent or reduce long-term health issues associated with hypertension by providing a comprehensive risk assessment and management plan.
Designed for preterm infants from 27 weeks to 34 weeks and up to 6 days post-menstrual age, Premie BiliRecs provides guidance on phototherapy and exchange transfusions for managing hyperbilirubinemia. It factors in the infant's post-menstrual age and total bilirubin levels to offer tailored recommendations, ensuring timely and effective treatment.
An interactive guide for blood transfusions offering evidence-based recommendations. It simplifies the decision-making process for clinicians, providing comprehensive guidance to ensure safe and effective transfusion practices, thereby alleviating some of the uncertainties involved while minimizing potential risks.
A utility designed to optimize the administration of total parenteral nutrition (TPN). It calculates the optimal TPN cycle flow rates to ensure patients receive appropriate nutrition over a specified time period, enhancing patient care and nutritional support.